en

PRODUCT DETAIL

Gliclazide Medreg 30 mg

Code 2298E
MA number 18/0273/22-S
Product Form: tbl plg 10x30 mg (blis.PVC/PVDC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B Blood glucose lowering drugs, excl. insulins
A10BB Sulfonylureas
A10BB09 Gliclazide
Shelf life: 36
Container: blister PVC/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 29.11.2022
Validity: 29.11.2027
SPC: SPC_Gliclazide Medreg 30 a 60 mg_11 2022.pdf  
PIL: PIL_Gliclazide Medreg 30 mg_10.2023.pdf  
Safety feature Yes
Data update: 06.12.2022
eu-flag.png sk-flag.png